HOME >> BIOLOGY >> NEWS
ICSI: Is it really safe?

Vienna, Austria: The absolute risk of having a baby with a serious congenital malformation or chromosomal abnormality as a result of using ICSI* is small, Dr Ulla-Britt Wennerholm told a news briefing today (Monday 1 July) at the annual conference of the European Society of Human Reproduction and Embryology in Vienna.

"Intracytoplasmic sperm injection (ICSI) has made conception possible for many couples with male factor infertility and a previously bad prognosis, but, as for all other reproductive technologies ICSI must be safe as well as effective," she said.

Concern at findings this year in an Australian study of ICSI prompted ESHRE to examine the totality of the evidence. Dr Wennerholm and her colleague Professor Christina Bergh, both from the Department of Obstetrics and Gynaecology at the Institute for Health of Women and Children in Sahlgrenska University Hospital in Gteborg, Sweden, carried out the review.

"From the beginning ICSI has been considered a more risky procedure than conventional IVF, but so far the majority of later studies found no increase in congenital malformations in children born after conventional IVF or ICSI," said Dr Wennerholm.

An alarmingly high prevalence of major birth defects after ICSI and IVF was found in the Australian register study** with the figure being twice as high for ICSI and IVF children as for normally conceived children - 8.6% of 301 infants conceived with ICSI and 9% of IVF children compared with 4.2% of normally conceived babies. "However, a major problem with this study was that it contained only a small number of ICSI and IVF children," said Dr Wennerholm.

At the same time, a recent Belgian*** study comparing children born after ICSI and IVF concluded that the major malformations between the two groups were comparable. The study lacked a naturally conceived control group but the rates were comparable to the naturally born children in the Australian study.

In Sweden,**
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
European Society for Human Reproduction and Embryology
1-Jul-2002


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Regular physical activity really does boost immune system in older men
2. The blind really do hear better
3. Scientists find 75 percent of red snapper sold in stores is really some other species
4. The biological clock: What really makes us tick
5. Just how much water do we really need? The answer may depend on our age
6. Identifying cancer genes Will it really lead to better treatment?
7. Baboon fathers really do care about their kids
8. Scientists tackle the question: What will it really take to stop global warming?
9. Is the evidence for human replacement really clear?
10. Prescribed burning: Do we really know what were doing?
11. Age at first drink: What does it really mean?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... BARBARA, CALIFORNIA (PRWEB) , ... October 10, 2017 ... ... management, technological innovation and business process optimization firm for the life sciences and ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation ...
Breaking Biology Technology:
Cached News: